58 filings
8-K
DMAC
DiaMedica Therapeutics Inc
10 Apr 24
Departure of Directors or Certain Officers
4:36pm
8-K
DMAC
DiaMedica Therapeutics Inc
19 Mar 24
DiaMedica Therapeutics Provides a Business Update and Announces Full Year 2023 Financial Results
4:16pm
8-K
DMAC
DiaMedica Therapeutics Inc
13 Nov 23
DiaMedica Therapeutics Provides a Business Update and Announces Third Quarter 2023 Financial Results
4:52pm
8-K
DMAC
DiaMedica Therapeutics Inc
5 Sep 23
Departure of Directors or Certain Officers
4:15pm
8-K
DMAC
DiaMedica Therapeutics Inc
14 Aug 23
DiaMedica Therapeutics Provides a Business Update and Announces Second Quarter 2023 Financial Results
4:25pm
8-K
87la1gc7v 63cu
21 Jun 23
DiaMedica Therapeutics Announces $37.5 Million Private Placement
8:42am
8-K
dfpjircd1s9b32
21 Jun 23
Regulation FD Disclosure
8:25am
8-K
pz62lop2 jnus
21 Jun 23
DiaMedica Therapeutics Announces that the FDA Has Removed The Clinical Hold On DM199 Phase 2/3 Trial For Ischemic Stroke
8:16am
8-K
qrd mt6q41i
30 May 23
DiaMedica Therapeutics Announces Appointment of Dr. Richard Kuntz to the Board of Directors
8:30am
8-K
9i4yodmwjr ycpkc9bok
22 May 23
Regulation FD Disclosure
5:01pm
8-K
y8g866r82 72
18 May 23
Amendments to Articles of Incorporation or Bylaws
4:30pm
8-K
3b16k
15 May 23
DiaMedica Therapeutics Provides a Business Update and Announces First Quarter 2023 Financial Results
4:31pm
8-K
9bxpvznyvuu
28 Mar 23
DiaMedica Therapeutics Provides a Business Update and Announces Full Year 2022 Financial Results
4:30pm
8-K
o3ysherse80p8d695172
10 Mar 23
Regulation FD Disclosure
4:43pm
8-K/A
6453u i0vteuc
10 Mar 23
Departure of Directors or Certain Officers
8:00am
8-K
gxutzn1ddmys5wf3
6 Mar 23
DiaMedica Therapeutics Announces the Appointment of Biopharma Veteran Tanya Lewis to Its Board of Directors
8:30am
8-K
ymb3jvox 5vt
9 Nov 22
DiaMedica Therapeutics Provides a Business Update and Announces Third Quarter 2022 Financial Results
4:20pm
8-K
ahpyqxfx
26 Oct 22
DiaMedica Therapeutics Provides Update on ReMEDy2 Trial
4:30pm
8-K
lqn1kjjjus01umxo
10 Aug 22
DiaMedica Therapeutics Provides a Business Update and Announces Second Quarter 2022 Financial Results
5:22pm
8-K
xzwii
6 Jul 22
DiaMedica Therapeutics Announces Clinical Hold of its Phase 2/3 ReMEDy2 Clinical Trial for DM199
4:30pm